Brazil Rabies Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rabies Vaccine market is growing globally due to the rising incidence of rabies, government initiatives and vaccination programs, growing pet ownership and animal healthcare realizing the importance of vaccination, technological advancements leading to more safe and effective vaccines, collaborations and partnerships between vaccine manufacturers and government bodies. Serum Institute of India Pvt. Ltd, Novartis AG, Cadila Pharmaceuticals, and Merck & Co., Inc., Sanofi, ADS Diagnostic Ltd, GSK plc, Berna Biotech Pharma GmbH, and AstraZeneca are the key global market players in rabies vaccine market.
Brazil Remicade Biosimilar Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Remicade Biosimilar market is growing globally due to the rising prevalence of autoimmune illnesses including rheumatoid arthritis, plaque psoriasis, introduction of a biosimilar version could provide financial relief for healthcare systems and increased access to essential medication for patients, quicker intravenous administration reaction times, patent expiry of branded versions will create opportunity biosimilars over other branded counterparts, thus increasing remicade biosimilar demand, growing awareness about its long-term benefits and better reimbursement scenario, technological advancements in the field of biosimilars, an increase in R&D spending by pharmaceutical companies and growing awareness about biosimilars among healthcare professionals and patients. Janssen Biotech Inc., Merck &Co., Pfizer Inc. (AC. Hospira), Celltrion Inc., Alvogen, Napp Pharmaceuticals, and Nippon Kayaku are some major players in the global Remicade (infliximab mAb) market.
Brazil Renal Cancer Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Renal Cancer Drugs market is growing globally due to the increasing incidences of kidney diseases and renal cancer, increased demand for immunotherapies, research and development spending on new drug development, growing aging population, increasing healthcare expenditure and favorable reimbursement policies for renal cancer drugs. Pfizer Inc, AstraZeneca, Bristol-Myers Squibb Company, Dr. Reddy's Laboratories Ltd, Endo International plc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Mylan N.V., Novartis AG, Lupin, Cipla Inc, Aurobindo Pharma, Fresenius SE & Co. KGaA, Sanofi, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd, Abbott are the key global market players in renal cancer drugs market.
Brazil Respiratory Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Respiratory Drugs market is growing globally due to the rising elderly population, rising respiratory disease prevalence and technological developments in respiratory medications, growing demand for combination therapies due to the rising prevalence of multi-drug-resistant bacteria, and technological advancements in drug delivery devices. The chronic obstructive pulmonary disease (COPD) segment is projected to grow at the highest CAGR during the forecast period owing to the increasing prevalence of COPD across the globe. Allied Healthcare, Cardinal Health, Covidien, Drager Medical, DeVilbiss Healthcare, Fisher & Paykel Healthcare, Getinge, Hamilton Medical, Invacare Corporation, NSpire Health and ResMed are the key global market players in respiratory drugs market.
Brazil Rheumatoid Arthritis Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rheumatoid Arthritis Drugs market is growing globally due to the growing aging population, increasing prevalence of rheumatoid arthritis, growing development in biologics, advancements in treatment options, increasing investment in research and development activities, increasing patient awareness and diagnosis and increased technological advancements. Pfizer Inc., Abbvie Inc., Novartis AG, Amgen Inc., Boehringer Ingelheim International GmbH., Merck & Co Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca, Ampio Pharmaceuticals Inc., Lilly, Fresenius Kabi AG, Bayer AG, Casper Pharma, Dr. Reddy's Laboratories Ltd., Norbrook.
Brazil Rituximab Biosimilars Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rituximab biosimilars market is growing globally due to the government initiatives, increased healthcare expenditure, increase in biopharmaceutical R&D expenditure, low cost of biosimilars, aging population, increase in healthcare access, patent expiry of reference product, rising prevalence of chronic diseases and growing acceptance and confidence for biosimilars. Teva Pharmaceuticals, Novartis AG, Pfizer, BIOCAD, and Shanghai Henlius Biotech, Inc. are the key global market players in Rituximab Biosimilars Market.
Brazil Rotavirus Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rotavirus Vaccine market is growing globally due to the rising burden of rotavirus infection, government immunization programs, increasing awareness and education about rotavirus infection, improved vaccine coverage, research and development activities to improve the safety and efficacy of rotavirus vaccine, international support from world health organization. Merck & Co., Inc., Bharat Biotech, GlaxoSmithKline plc., Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd, BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Biological E, Bio Farma, Novartis AG, Berghofer Medical Research Institute, Pfizer, Inc., CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson Services, Inc., AstraZeneca, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation., DAIICHI SANKYO COMPANY, LIMITED are the key global market players in rotavirus vaccine market.
Brazil Sarcoma Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Sarcoma Drugs market is growing globally due to the increasing incidence and prevalence of sarcoma, advances in research and development, development of targeted therapies, collaboration and partnerships between research organizations and pharmaceutical companies, patient advocacy and awareness programmes and support from regulatory authorities. Johnson & Johnson Private Limited, Abbott, AbbVie Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Pfizer Inc, Mylan N.V., Bristol-Myers Squibb Company, GSK plc., Bayer AG are the key market players in global sarcoma drugs market.
Brazil Seasonal Flu Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Seasonal Flu Vaccine market is growing globally due to the rising awareness of the necessity of getting the flu shot and the initiatives to expand immunization programmes, expanding government support and focus on seasonal flu vaccination, robust research and development activities with strong pipeline candidates, high influenza rates among children owing to demand for pediatric vaccines. GlaxoSmithKline, AstraZeneca, Seqirus, Pfizer, Novartis, Johnson & Johnson, Daiichi Sankyo Company, Bharat Biotech International Limited, Mitsubishi Tanabe Pharma Corporation are the key global market players in Seasonal flu vaccine market.
Brazil SGLT2 Inhibitor Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. SGLT2 Inhibitor market is growing globally due to the rising prevalence of type 2 diabetes, Efficacy and Safety Profile of these drugs is good in treating type 2 diabetes, promoting weight loss and protecting from cardiovascular diseases, expanded indications of these drugs to include management of heart failure with reduced ejection fraction and chronic kidney disease, advancements in drug development. Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals and Astellas are the key market players operating globally.
Brazil Skin Tightening Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Skin Tightening market is growing globally due to the rising demand for minimally invasive cosmetic operations, increased interest in aesthetic procedures, rise in healthcare expenditures, improvements in skin tightening technology and an ageing population seeking skin rejuvenation procedures, the creation of cutting-edge skin tightening technologies, as well as strategic alliances or partnerships between major firms. Merz Pharma, ALLERGAN, BISON MEDICAL, Pollogen, BRERA MEDICAL TECHNOLOGIES S.R.L., Cutera, Opatra Ltd, Venus Concept, Alma Lasers, Beijing Winkonlaser Technology Limited, DEKA M.E.L.A. srl, Fotona, ThermiGen, LLC, Hologic, Inc, EINSMED Co. Ltd and Bausch Health Companies Inc. are the key global market players.
Brazil Sleep Aid Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Sleep Aid market is growing globally due to the global population growth, increased consumer awareness of portable sleep apnea devices, rapid adoption of sensors and wearable monitors, rising personal disposable income among the big companies, rising prevalence of sleep disorders, increasing awareness about the importance of healthy sleep, lifestyle changes leading to sleep disturbances, and the growing elderly population. Koninklijke Philips N.V., Itamar Medical Ltd., Natus Medical Incorporated, CONTEC MEDICAL SYSTEMS CO., LTD, ResMed, BMC Medical Co., Ltd., SomnoMed, Fisher & Paykel Healthcare Limited, Somnowell, Compumedics Limited, APEX MEDICAL CORP., Inspire Medical Systems, Inc., NIHON KOHDEN CORPORATION, DeVilbiss Healthcare LLC, nox medical, Advanced Brain Monitoring, Inc., Cleveland Medical Devices Inc., Braebon Medical Corporation, and Löwenstein Medical Technology GmbH + Co. KG are the key global market players in Sleep Aid Market.
Brazil Subcutaneous Immunoglobulin Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Subcutaneous Immunoglobulin market is growing globally due to the Increasing prevalence of chronic and autoimmune diseases, the trend towards providing healthcare in the patient's home, improvements in infusion technology, and the advantages and benefits of subcutaneous delivery, rise in the prevalence of sedentary lifestyle due to urbanization and stress. Baxter, Biotest AG., China Biologic Products Holdings, Inc., CSL Limited, Grifols, S.A., Kedrion S.p.A, Octapharma, GREEN CROSS CORP, Coram LLC, Momenta Pharmaceuticals, Option Care Enterprises, Inc., ADMA Biologics, Inc., Gentian Diagnostics AS, Mabtech, J. Mitra & Co. Pvt. Ltd, Cygnus Technologies, Kamada Pharmaceuticals are the key global market players in subcutaneous immunoglobulin market.
Brazil Supportive Care Agents in Cancer Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Supportive Care Agents in Cancer market is growing globally due to the increasing cancer incidence which causes growth in need for effective supportive care measures to manage treatment-related symptoms and improve patients' quality of life, side effects caused by cancer treatments which require supportive care, growing emphasis on patient-centered care, increased awareness and education among patients and healthcare professionals, support by regulatory bodies and launch of new products. Acacia Pharma Group Plc, Teva Pharmaceuticals Industries Ltd, Fagron Group, KYOWA HAKKO BIO CO., LTD., APR, and F. Hoffmann-La Roche Ltd are the key global market players in supportive care agents in cancer market.
Brazil Systemic Lupus Erythematosus Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Systemic Lupus Erythematosus market is growing globally due to the rise in the prevalence of systemic lupus erythematosus across the world, increasing geriatric population and rising healthcare expenditure, advances in research and development for introduction of novel therapies, Growing Awareness and Diagnosis and Government Initiatives and Support. GlaxoSmithKline plc, AstraZeneca plc, Eli Lilly and Company, Bristol Myers Squibb Company, Pfizer Inc., Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Sanofi, AbbVie Inc. are the key global market players in Systemic Lupus Erythematosus Market.
Brazil T-Cell Lymphoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. T-Cell Lymphoma market is growing globally due to the High lymphoma cancer incidence rate, rising healthcare expenditure, rising number of geriatric population, increasing risk of lymphoma due to autoimmune disorders, high disposable income, advancement in T-cell lymphoma-specific therapies, unmet medical needs, advances in diagnostic techniques and increasing utilization of immunotherapies. Bristol Myers Squibb Company, Novartis AG, Kyowa Kirin Co., Ltd., Merck & Co., Inc., Seattle Genetics, Inc., Spectrum Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., BeiGene, Ltd., and Epizyme, Inc. are the key global market players in T-Cell Lymphoma Market.
Brazil Tetanus Toxoid Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Tetanus toxoid vaccine market is growing globally due to the government initiatives like mandatory immunization programs, increasing awareness among individuals and healthcare professionals about the importance of tetanus vaccination, improved healthcare infrastructure which has facilitated the distribution and administration of tetanus toxoid vaccines, technological advancements in vaccine manufacturing techniques including improved purification methods and rising Incidence of tetanus cases. Sanofi Pasteur, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech, Biological E. Limited are the key global market players in tetanus toxoid vaccine market.
Brazil Thin Film Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Thin Film Drugs market is growing globally due to the pediatric and geriatric applications as they have difficulty in swallowing conventional tablets, technological advancements like development of innovative film-forming materials, improved manufacturing processes and enhanced drug delivery systems, better patient convenience and compliance thereby improving medication adherence, rapid drug absorption and improved bioavailability and increase in research and development activities. Pfizer Inc., Novartis AG, GlaxoSmithKline plc (GSK), Johnson & Johnson Services, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Aquestive Therapeutics, Inc., Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp., ZIM Laboratories Ltd., Indivior PLC, MonoSol Rx (A Subsidiary of MonoSol LLC), LTS Lohmann Therapie-Systeme AG, APR Applied Pharma Research s.a., CURE Pharmaceutical Holding Corp. are the key global market players in thin film drugs market.
Brazil TNF Inhibitors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. TNF Inhibitors market is growing globally due to the rising prevalence of autoimmune diseases like rheumatoid arthritis, psoriasis, psoriatic arthritis, inflammatory bowel disease for which TNF Inhibitors are used. Increase in number of research and development activities in tumor necrosis factor (TNF) inhibitor drugs, increasing acceptance of biologic therapies, expanding indications of TNF Inhibitors like dermatologic disorders, ophthalmic diseases, and neurological disorders and growth in ageing population. AbbVie Inc., Amgen Inc., Johnson & Johnson (Janssen Biotech, Inc.), Pfizer Inc., Novartis International AG, UCB S.A., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Samsung Bioepis Co., Ltd., Sandoz International GmbH are the key global market players in TNF Inhibitors Market.
Brazil Top Selling Biologics Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing research and development activities and favorable reimbursement policies act as market growth drivers. Some of the major players in this market are Roche/Genentech, Johnson & Johnson, AbbVie, Amgen etc.
Brazil Topical Drugs Delivery Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Topical drugs delivery market is growing globally due to the rising incidence and prevalence of various skin disorders, such as acne, eczema, psoriasis, and dermatitis, advancements in formulation technologies like nano emulsions, liposomes, micelles, and transdermal patches, patient preference for non-invasive treatment that minimize side effects and offer localized therapy, growing aging population, rising demand for dermatological cosmetics due to focus on personal grooming, increased research and development activities and favorable regulatory environments. Johnson & Johnson Private Limited, Nestlé India Ltd., Novartis AG, GlaxoSmithKline plc, Bausch Health Companies Inc., Merck & Co Inc., Bayer AG, Hisamitsu Pharmaceutical Co.,Inc., Glenmark Pharmaceuticals Limited are the key global market players in topical drugs delivery market.
The Brazil Asthma and COPD Therapeutics Market was valued at US $0.84 Bn in 2022, and is predicted to grow at (CAGR) of 6.20% from 2023 to 2030, to US $1.35 Bn by 2030. The key drivers of this industry include the rising prevalence of COPD and Asthma, economic growth, technological advancements, and others. The industry is primarily dominated by players such as, GlaxoSmithKline, Teva, Merck, Novartis, AstraZeneca, Pfizer, Boehringer Ingelheim among others.
Brazil Antibacterial (Antibiotics) Drugs Market is at around $21.38 Bn in 2023 and is projected to reach $24.9 Bn in 2030, exhibiting a CAGR of 2.2% during the forecast period. The market is expanding due to factors such as population growth, rising healthcare costs, and an increase in the incidence of infectious diseases. The market is dominated by key players like EMS Pharmaceutica S.A., Abbott Laboratories, Pfizer, AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Sanofi S.A., Novartis AG, and Roche Holding AG.
Brazil Cardiovascular Drug Market is at around $3.5 Bn in 2022 and is projected to reach $5.03 Bn in 2030, exhibiting a CAGR of 4.8% during the forecast period. Primary factors driving the expansion of this industry include government initiatives, increasing prevalence of cardiovascular diseases, and an aging population. The market is dominated by key players like Eurofarma, Nortec QuÃmica (BRA), Drogaria do Povo (BR), Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca, Sanofi, Novartis AG, and Merck & Co., Inc.
Brazil Dermatological Therapeutics Market is at around $1.03 Bn in 2023 and is projected to reach $1.96 Bn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The market is growing due to factors such as rising dermatological disorders, e-commerce and digital marketing, and technological advancements. The market is dominated by key players like Hypermarcas, Ache Laboratorios Farmaceuticos S.A., EMS: Industria Farmaceutica S.A., Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.